Jardemark, Kent, Department of Physiology and Pharmacology, Section of Neuropsychopharmacology, Karolinska Institutet, Stockholm
-
Vol 2, No 1 (2009): Abstracts from SCNP 50th annual meeting - SCNP Meeting POSTERS
Reboxetine enhances the antipsychotic-like effect of olanzapine and facilitates cortical dopaminergic and NMDA receptor-mediated transmission in analogy with clozapine.
Abstract
ISSN 1903-7236